Experimental treatments do not need emergency approval to be administered in Canada?

www.facebook.com/groups/Stand4THEE/permalink/1696857873831426/

(…)

<<Health Canada has NOT approved them under Emergency Use Authorization (EUA). The FDA HAS approved them under an EUA and while Canada does take direction from the FDA and the CDC (Canada pays these organizations), Canada has set out its own acceptance guidelines for these injections.

This is why in Canada we do not need a declared emergency to administer the jab – so it appears. So while the ROA is unenforceable, read previous post , the jab can still be administered based on the criterium set forth in the interim order. Sadly and frustratingly so.

ALL the jabs are approved by Health Canada using either an Interim Order or with conditions. See the details below. Yes, there is some reading involved if you want to INFORM and EDUCATE yourself.

Pfizer status:

https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/74541a-eng.php

– for use under interim order

Moderna:

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna/authorization.html

– approved for use under conditions

https://laws-lois.justice.gc.ca/eng/acts/f-27/page-8.html

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/janssen.html

– The vaccine is approved for people who are 18 years of age and older. Its safety and effectiveness in people younger than 18 years of age have not yet been established.

AstraZeneca:

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca/authorization.html

– for use under an interim order

Interim order definition:

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html

Guidelines under the interim order:

https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance.html

From the document:

“Updated: May 3, 2021

This guidance document supports the Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19 (IO No. 2), which was made pursuant to subsection 30.1(1) of the Food and Drugs Act. IO No. 2 was signed by the Minister on May 3, 2021, which replaced the first interim order (IO No. 1).

The document provides guidance to:

applicants seeking authorization to conduct COVID-19 drug ‼ clinical trials‼ under the interim order (IO No. 2)

applicants and authorization holders of COVID-19 drug ‼ clinical trials‼ who held authorization under IO No. 1”

Food and Drug Act, Section 30:

https://laws-lois.justice.gc.ca/eng/acts/f-27/page-8.html

Please do take a few minutes to read, you don’t have to read a lot to understand. Most of the nuggets you need are listed at the top and are only a few lines of copy.>>